Smith Darren Charlton
SEC CIK 2122447 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TLX | Telix Pharmaceuticals Ltd | Group CFO | 14.0K | $20.0K | — | 2 | 2026-03-29 | 2026-09-07 |
Most active insiders at TLX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Behrenbruch Christian | MD, Group CEO, Dir | $996.7K | — |
| 2 | Smith Darren Charlton | Group CFO | $20.0K | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 19:20 | 2026-09-07 | TLX | Telix Pharmaceuticals Ltd | Smith Darren Charlton | Group CFO | P - Purchase | $9.66 | +2,071 | 14.0K | +17% | +$20.0K | |
| D | 2026-04-01 19:14 | 2026-03-29 | TLX | Telix Pharmaceuticals Ltd | Smith Darren Charlton | Group CFO | M - OptEx | $0.00 | +1,111 | 11.9K | +10% | $0 |
Purchase Sale Sale after option exercise All abbreviations